Literature DB >> 10223295

Protein fold analysis of the B30.2-like domain.

M H Seto1, H L Liu, D A Zajchowski, M Whitlow.   

Abstract

The B30.2-like domain occurs in some members of a diverse and growing family of proteins containing zinc-binding B-box motifs, whose functions include regulation of cell growth and differentiation. The B30.2-like domain is also found in proteins without the zinc-binding motifs, such as butyrophilin (a transmembrane glycoprotein) and stonustoxin (a secreted cytolytic toxin). Currently, the function for the B30.2-like domain is not clear and the structure of a protein containing this domain has not been solved. The secondary structure prediction methods indicate that the B30.2-like domain consists of fifteen or fewer beta-strands. Fold recognition methods identified different structural topologies for the B30.2-like domains. Secondary structure prediction, deletion and lack of local sequence identity at the C-terminal region for certain members of the family, and packing of known core structures suggest that a structure containing two beta domains is the most probable of these folds. The most C-terminal sequence motif predicted to be a beta-strand in all B30.2-like domains is a potential subdomain boundary based on the sequence-structure alignments. Models of the B30.2-like domains were built based on immunoglobulin-like folds identified by the fold recognition methods to evaluate the possibility of the B30.2 domain adopting known folds and infer putative functional sites. The SPRY domain has been identified as a subdomain within the B30.2-like domain. If the B30.2-like domain is a subclass of the SPRY domain family, then this analysis would suggest that the SPRY domains are members of the immunoglobulin superfamily.

Mesh:

Substances:

Year:  1999        PMID: 10223295

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  15 in total

Review 1.  Structure and function of the SPRY/B30.2 domain proteins involved in innate immunity.

Authors:  Akshay A D'Cruz; Jeffrey J Babon; Raymond S Norton; Nicos A Nicola; Sandra E Nicholson
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

2.  Milk lipid secretion: recent biomolecular aspects.

Authors:  James L McManaman
Journal:  Biomol Concepts       Date:  2012-12-01

3.  Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.

Authors:  Kulkarni Prakash; Gregorio Pirozzi; Michael Elashoff; William Munger; Iwao Waga; Rajiv Dhir; Yoshiyuki Kakehi; Robert H Getzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.

Authors:  Byeongwoon Song; Bert Gold; Colm O'Huigin; Hassan Javanbakht; Xing Li; Matthew Stremlau; Cheryl Winkler; Michael Dean; Joseph Sodroski
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.

Authors:  Matthew Stremlau; Michel Perron; Sohanya Welikala; Joseph Sodroski
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 6.  Molecular evolution of the antiretroviral TRIM5 gene.

Authors:  Welkin E Johnson; Sara L Sawyer
Journal:  Immunogenetics       Date:  2009-02-24       Impact factor: 2.846

7.  Trim5alpha protein restricts both HIV-1 and murine leukemia virus.

Authors:  Melvyn W Yap; Sébastien Nisole; Clare Lynch; Jonathan P Stoye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.

Authors:  Zuzana Keckesova; Laura M J Ylinen; Greg J Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

9.  A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies.

Authors:  Judith N Torimiro; Hassan Javanbakht; Felipe Diaz-Griffero; Jonghwa Kim; Jean K Carr; Mary Carrington; Julie Sawitzke; Donald S Burke; Nathan D Wolfe; Michael Dean; Joseph Sodroski
Journal:  Virology       Date:  2009-07-03       Impact factor: 3.616

10.  Expression of butyrophilin (Btn1a1) in lactating mammary gland is essential for the regulated secretion of milk-lipid droplets.

Authors:  Sherry L Ogg; Anne K Weldon; Lorraine Dobbie; Andrew J H Smith; Ian H Mather
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.